Skip to main content
Top
Published in: Supportive Care in Cancer 4/2019

Open Access 01-04-2019 | Original Article

Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease

Authors: Moniek van Zutphen, Anouk Geelen, Hendriek C. Boshuizen, Renate M. Winkels, Anne J.M.R. Geijsen, Evertine Wesselink, Merel Snellen, Dieuwertje E. Kok, Johannes H.W. de Wilt, Paul C. van de Meeberg, Ewout A. Kouwenhoven, Henk K. van Halteren, Ernst J. Spillenaar Bilgen, Ellen Kampman, Fränzel J.B. van Duijnhoven

Published in: Supportive Care in Cancer | Issue 4/2019

Login to get access

Abstract

Purpose

Previous studies have shown that > 50% of colorectal cancer (CRC) patients treated with adjuvant chemotherapy gain weight after diagnosis. This may affect long-term health. Therefore, prevention of weight gain has been incorporated in oncological guidelines for CRC with a focus on patients that undergo adjuvant chemotherapy treatment. It is, however, unknown how changes in weight after diagnosis relate to weight before diagnosis and whether weight changes from pre-to-post diagnosis are restricted to chemotherapy treatment. We therefore examined pre-to-post diagnosis weight trajectories and compared them between those treated with and without adjuvant chemotherapy.

Methods

We included 1184 patients diagnosed with stages I–III CRC between 2010 and 2015 from an ongoing observational prospective study. At diagnosis, patients reported current weight and usual weight 2 years before diagnosis. In the 2 years following diagnosis, weight was self-reported repeatedly. We used linear mixed models to analyse weight trajectories.

Results

Mean pre-to-post diagnosis weight change was −0.8 (95% CI −1.1, −0.4) kg. Post-diagnosis weight gain was + 3.5 (95% CI 2.7, 4.3) kg in patients who had lost ≥ 5% weight before diagnosis, while on average clinically relevant weight gain after diagnosis was absent in the groups without pre-diagnosis weight loss. Pre-to-post diagnosis weight change was similar in patients treated with (−0.1 kg (95%CI −0.8, 0.6)) and without adjuvant chemotherapy (−0.9 kg (95%CI −1.4, −0.5)).

Conclusions

Overall, hardly any pre-to-post diagnosis weight change was observed among CRC patients, because post-diagnosis weight gain was mainly observed in patients who lost weight before diagnosis. This was observed independent of treatment with adjuvant chemotherapy.
Literature
2.
go back to reference Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, Cespedes Feliciano EM, Xiao J, Caan BJ (2017) Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomark Prev 26(1):30–37. https://doi.org/10.1158/1055-9965.EPI-16-0145 CrossRef Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, Cespedes Feliciano EM, Xiao J, Caan BJ (2017) Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomark Prev 26(1):30–37. https://​doi.​org/​10.​1158/​1055-9965.​EPI-16-0145 CrossRef
6.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2017) Continuous update project report: diet, nutrition, physical activity and colorectal cancer. Available at: wcrf.org/colorectal-cancer-2017 World Cancer Research Fund/American Institute for Cancer Research (2017) Continuous update project report: diet, nutrition, physical activity and colorectal cancer. Available at: wcrf.​org/​colorectal-cancer-2017
8.
go back to reference Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, Forsythe LP, Rowland JH (2015) The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. Journal of Cancer Survivorship: Research and Practice 9(2):239–251. https://doi.org/10.1007/s11764-014-0403-1 CrossRef Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, Forsythe LP, Rowland JH (2015) The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. Journal of Cancer Survivorship: Research and Practice 9(2):239–251. https://​doi.​org/​10.​1007/​s11764-014-0403-1 CrossRef
10.
go back to reference Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS, Cancer, Leukemia Group B (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and leukemia group B 89803. J Clin Oncol 26(25):4109–4115. https://doi.org/10.1200/JCO.2007.15.6687 CrossRefPubMedPubMedCentral Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS, Cancer, Leukemia Group B (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and leukemia group B 89803. J Clin Oncol 26(25):4109–4115. https://​doi.​org/​10.​1200/​JCO.​2007.​15.​6687 CrossRefPubMedPubMedCentral
11.
go back to reference Winkels RM, Snetselaar T, Adriaans A, van Warmerdam LJC, Vreugdenhil A, Slooter GD, Straathof JW, Kampman E, van Lieshout R, Beijer S (2016) Changes in body weight in patients with colorectal cancer treated with surgery and adjuvant chemotherapy: an observational study. Cancer Treat Res Commun 9:111–115. https://doi.org/10.1016/j.ctarc.2016.09.002 CrossRef Winkels RM, Snetselaar T, Adriaans A, van Warmerdam LJC, Vreugdenhil A, Slooter GD, Straathof JW, Kampman E, van Lieshout R, Beijer S (2016) Changes in body weight in patients with colorectal cancer treated with surgery and adjuvant chemotherapy: an observational study. Cancer Treat Res Commun 9:111–115. https://​doi.​org/​10.​1016/​j.​ctarc.​2016.​09.​002 CrossRef
12.
go back to reference Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL, Quesenberry CP, Kwan ML, Prado CM (2017) Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study). Cancer Epidemiol Biomark Prev 26(7):1008–1015. https://doi.org/10.1158/1055-9965.EPI-17-0200 CrossRef Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL, Quesenberry CP, Kwan ML, Prado CM (2017) Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS study). Cancer Epidemiol Biomark Prev 26(7):1008–1015. https://​doi.​org/​10.​1158/​1055-9965.​EPI-17-0200 CrossRef
15.
go back to reference Van Leersum NJ, Snijders HS, Henneman D, Kolfschoten NE, Gooiker GA, ten Berge MG, Eddes EH, Wouters MW, Tollenaar RA, Dutch Surgical Colorectal Cancer Audit G, Bemelman WA, van Dam RM, Elferink MA, Karsten TM, van Krieken JH, Lemmens VE, Rutten HJ, Manusama ER, van de Velde CJ, Meijerink WJ, Wiggers T, van der Harst E, Dekker JW, Boerma D (2013) The Dutch surgical colorectal audit. Eur J Surg Oncol 39(10):1063–1070. https://doi.org/10.1016/j.ejso.2013.05.008 CrossRefPubMed Van Leersum NJ, Snijders HS, Henneman D, Kolfschoten NE, Gooiker GA, ten Berge MG, Eddes EH, Wouters MW, Tollenaar RA, Dutch Surgical Colorectal Cancer Audit G, Bemelman WA, van Dam RM, Elferink MA, Karsten TM, van Krieken JH, Lemmens VE, Rutten HJ, Manusama ER, van de Velde CJ, Meijerink WJ, Wiggers T, van der Harst E, Dekker JW, Boerma D (2013) The Dutch surgical colorectal audit. Eur J Surg Oncol 39(10):1063–1070. https://​doi.​org/​10.​1016/​j.​ejso.​2013.​05.​008 CrossRefPubMed
22.
go back to reference Olivarius NF, Andreasen AH, Loken J (1997) Accuracy of 1-, 5- and 10-year body weight recall given in a standard questionnaire. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 21(1):67–71CrossRef Olivarius NF, Andreasen AH, Loken J (1997) Accuracy of 1-, 5- and 10-year body weight recall given in a standard questionnaire. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 21(1):67–71CrossRef
Metadata
Title
Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease
Authors
Moniek van Zutphen
Anouk Geelen
Hendriek C. Boshuizen
Renate M. Winkels
Anne J.M.R. Geijsen
Evertine Wesselink
Merel Snellen
Dieuwertje E. Kok
Johannes H.W. de Wilt
Paul C. van de Meeberg
Ewout A. Kouwenhoven
Henk K. van Halteren
Ernst J. Spillenaar Bilgen
Ellen Kampman
Fränzel J.B. van Duijnhoven
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4560-z

Other articles of this Issue 4/2019

Supportive Care in Cancer 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine